Maven Securities’s Erasca ERAS Stock Holding History

Maven Securities’s Portfolio ERAS Stock Details ERAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-168,243	Closed	-$725K	–	967
2022 Q4	$725K	Buy	+168,243	New	+$1.14M	0.02%	492

Other funds holding ERAS

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Maven Securities's ERAS Position: Q1 2023 in Review

Maven Securities sold out of Erasca (ERAS) in Q1 2023, closing a stake of 168,243 shares — an estimated $725K sold.

Maven Securities first reported a position in ERAS in Q4 2022 and held it in 1 quarter. The position peaked at $725K in Q4 2022. 117 funds tracked by Wall St. Rank hold ERAS as of Q1 2023.

Maven Securities reported no remaining Erasca position as of Q1 2023 after selling out during the quarter.
Maven Securities sold 168,243 Erasca shares in Q1 2023, an estimated $725K.
Maven Securities first reported a position in Erasca in Q4 2022 and held it in 1 quarter.
Maven Securities's Erasca position peaked at $725K in Q4 2022.
117 funds tracked by Wall St. Rank held Erasca as of Q1 2023.

Based on Maven Securities's 13F filing for Q1 2023, filed 15 May 2023.